ANI Pharmaceuticals | ANIP - Cost Of Sales

Stock Price
81.84
Daily Change
0.34 0.42%
Monthly
2.98%
Yearly
35.16%
Q1 Forecast
79.33

ANI Pharmaceuticals reported $116.02M in Cost of Sales for its fiscal quarter ending in September of 2025.





Cost Of Sales Change Date
AbbVie USD 4.55B 757M Dec/2025
ANI Pharmaceuticals USD 116.02M 18.12M Sep/2025
Aurora Cannabis CAD 58.08M 11.99M Sep/2025
Canopy Growth CAD 44.78M 9.32M Sep/2025
Eli Lilly USD 3.37B 363.7M Dec/2025
Hikma Pharmaceutical USD 466.5M 428.5M Jun/2025
Knight Therapeutics CAD 47.25M 990K Sep/2024
Novartis USD 3.54B 216M Sep/2025
Perrigo USD 666.2M 27.2M Sep/2025
Sun Pharmaceuticals INR 36.77B 348M Dec/2025
Teva Pharmaceutical Industries USD 2.06B 120M Dec/2025